You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Reliable Manufacturing of Scandia-doped Tungsten Powders for Thermionic Cathodes

    SBC: NGIMAT, LLC            Topic: N15AT010

    In this Phase II STTR effort, nGimat will partner with the University of Kentucky (UK) and 3M/Ceradyne to continue development of W-scandate cathode composite materials. Compared to conventional M-type cathodes, these composite scandate nanomaterials will enable longer cathode lifetime by lowering the required operating temperature. nGimat is an established and successful powder manufacturing comp ...

    STTR Phase II 2017 Department of DefenseNavy
  2. Vortex Preserving and Consistent Large Eddy Simulations for Naval Applications

    SBC: Kord Technologies, Inc.            Topic: N15AT002

    An integrated program of fundamental research, software development and technology transition to Navy target platforms for computationally efficient yet accurate prediction of turbulence interactions involving disparate length scales has been proposed and is underway. The fundamental research will be conducted at Purdue University and provide a critical modeling component for turbulence resolving ...

    STTR Phase II 2017 Department of DefenseNavy
  3. Commercialization of a Novel Therapeutic for Alzheimer's Disease

    SBC: CoPlex Therapeutics, LLC            Topic: NIA

    ABSTRACT Traditional mon therapeutictarget driven approaches to drug development for Alzheimer s diseaseADare becoming increasingly expensive and in many cases disappointingly unsuccessfulBased on preliminary in vitro and in vivo studies we have identified a novel small moleculemethyldimethyloxodihydrobenzo cnaphthyridinecarboxylateBNCthat significantly decreases neuroinflammation and production o ...

    STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  4. Development of Adaptive Closure Models for Large Eddy Simulations of Lean Blow-Out Conditions

    SBC: CFD RESEARCH CORPORATION            Topic: AF16AT14

    The objective of the proposed Phase II effort is to establish fundamental understanding of combustion-physical mechanisms leading to blowout, the critical evaluation of model limitations in predicting these blowout processes and the development of an improved combustion model to enable the prediction of lean blowout (LBO) in swirl-stabilized combustors. For this, high-resolution numerical simulati ...

    STTR Phase II 2017 Department of DefenseAir Force
  5. Embedded Space Analytics

    SBC: INFOBEYOND TECHNOLOGY LLC            Topic: N16AT020

    Navy needs a real-time graph embedding tool for analyzing huge graphs (millions of nodes and billions of edges) from diverse sources. However, current approaches cannot provide dynamic and scalable graph analytics to signify the military value of tactical data. In this project, InfoBeyond advocates EStreaming (Embedding & Streaming) for scalable and efficient graph streaming. EStreaming promotes b ...

    STTR Phase II 2017 Department of DefenseNavy
  6. Personalized dosing of dichloroacetate for the treatment of rare and common diseases

    SBC: Medosome Biotec, LLC            Topic: NICHD

    Pyruvate dehydrogenase complexPDCdeficiencyPDCDis a rare disease of mitochondrial energy failure in which the life of expectancy of affected children is severely truncatedTreatment of PDCD remains a seriousunmetchallengeThere has never been a controlled trial of any intervention for PDCDthusthere is no proven therapy for affected patientsDichloroacetateDCArepresents the first targeted therapy for ...

    STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  7. System of Systems Control Interactions

    SBC: GTD Unlimited LLC            Topic: MDA15T002

    In this research effort, the GTD team will design tools for efficiently specifying, representing, and analyzing the interactions between control systems in System of Systems (SoS). Three approaches will be considered and integrated. The first two are based in the rigorous application of H_8 control theory to the SoS design problem. The third will use complexity measures to generate a metric that c ...

    STTR Phase II 2017 Department of DefenseMissile Defense Agency
  8. Lentiviral Vector for the treatment of Fanconi Anemia

    SBC: Rimedion, Inc.            Topic: NHLBI

    DESCRIPTIONprovided by applicantIn this Phase II STTR application Rimedion seeks to commercialize a novel treatment for patients suffering from Fanconi anemia and request funding for a Phase I II clinical trialThe product will utilize a HIVbased lentiviral vector expressin the Fanconi anemia A proteinThe strong scientific support for this approached is strengthened by a successful Phase I STTRThe ...

    STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  9. SA FasL engineered human islets as a novel product for the treatment of type diabetes

    SBC: FasCure Therapeutics LLC            Topic: NIDDK

    PROJECT SUMMARY Type diabetes T D is a chronic autoimmune disorder that affects of population worldwide Exogenous insulin treatment is the standard of care for T D but often negatively affects the quality of life and is ineffective in preventing recurrent hyperglycemia episodes and chronic complications Recent studies show that human islet allografts can restore long term normoglycemia ...

    STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  10. Auto-Docking Autonomous Burial Vehicle (AD-ABV)

    SBC: MAKAI OCEAN ENGINEERING INC            Topic: N11AT017

    Subsequent Phase II Proposal, extension of Phase II contract N00039-12-C-0082. This contract involves the development of an underwater vehicle that can reliably and autonomously interconnect power and data cables to undersea nodes after they have been deployed. The Auto-Docking Autonomous Burial Vehicle (AD-ABV) is a cable-connecting adaptation of Makai’s proven ABV, which has been successfully ...

    STTR Phase II 2017 Department of DefenseNavy
US Flag An Official Website of the United States Government